President and CEO Doug Love outlined a series of anticipated clinical and regulatory milestones during the 25th Annual ...

Investigational treatment improves outcomes without complete complement blockade ...

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...

Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...

Your home is a treasure chest of items that, with a little creativity, can find a new purpose in your backyard. Before you ...

Issued claims further strengthen global intellectual property portfolio supporting immune cell modulation platform and expand strategic presence in a high-growth international market LA JOLLA, CA, ...

Most gardeners choose their seeds before they choose their layout, and then spend years rearranging beds, regretting pathways, and wishing they’d thought it through first. This spring, start with the ...

There are places in this world that make you question whether you’ve accidentally wandered into someone else’s fantasy, and ...

If your answer is “never” or “only in my dreams,” then you clearly haven’t been to Rickwood Caverns State Park in Warrior, ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...